Ironwood to buy VectivBio for $1.15 bln to boost digestive disorder drugs portfolio R&D, Therapeutics As part of the deal, Ironwood will acquire VectivBio’s experimental therapy apraglutide, which Ironwood says could reach $1 billion in peak net sales. Read more May 22, 2023/by Reuters Health https://www.pharmalive.com/wp-content/uploads/2020/01/Pharmalive_4c-300x37.png 0 0 Reuters Health https://www.pharmalive.com/wp-content/uploads/2020/01/Pharmalive_4c-300x37.png Reuters Health2023-05-22 08:24:502023-05-22 09:38:51Ironwood to buy VectivBio for $1.15 bln to boost digestive disorder drugs portfolio
